Abstract
Although corticosteroids are an effective first-line therapy for minimal change disease, relapse, steroid dependence, and intolerance are common in this podocytopathy of unknown etiology. Reports that B cell–targeted therapies are efficiacious in some patients suggest an autoantibody-mediated
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have